David Mountcastle is CFO & VP at Privia Health Group, Inc. (PRVA). They have made 24 open-market trades across 1 company since 2021, most recently 2026-07-09.
CIK 0001858396
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 24 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PRVA | 164,853 | $3.7M |
Shares reported on the most recent Form 4, priced at the 2026-07-13 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PRVA | SELL · 10b5-1 | 2026-07-09 | 2026-07-13 | $27.67 | $589K | -9.5% | -21.9% | -22.2% |
| PRVA | SELL · 10b5-1 | 2026-07-07 | 2026-07-09 | $27.57 | $17K | -4.6% | -18.9% | -26.4% |
| PRVA | SELL · 10b5-1 | 2026-07-02 | 2026-07-07 | $27.50 | $680K | -0.5% | -18.5% | -24.1% |
| PRVA | SELL · 10b5-1 | 2026-06-26 | 2026-06-30 | $25.18 | $433K | +7.2% | -8.3% | -23.6% |
| PRVA | SELL | 2026-05-11 | 2026-05-13 | $22.60 | $77K | -2.9% | +2.5% | -3.7% |
| PRVA | SELL · 10b5-1 | 2026-05-01 | 2026-05-05 | $25.03 | $210K | -6.3% | -12.7% | -2.9% |
| PRVA | SELL | 2026-04-02 | 2026-04-06 | $20.85 | $116K | +8.0% | +10.1% | +25.0% |
| PRVA | SELL | 2026-03-16 | 2026-03-18 | $22.11 | $141K | -7.1% | +11.5% | +9.3% |
| PRVA | SELL | 2026-03-12 | 2026-03-16 | $21.71 | $283K | -8.6% | +6.1% | +4.1% |
| PRVA | SELL | 2026-03-06 | 2026-03-10 | $22.99 | $253K | -4.5% | +2.1% | -3.7% |
| PRVA | SELL | 2026-02-26 | 2026-03-02 | $25.03 | $327K | -8.0% | -10.8% | -9.8% |
| PRVA | SELL · 10b5-1 | 2025-12-12 | 2025-12-16 | $25.03 | $1.2M | +0.7% | +0.7% | -7.3% |
| PRVA | SELL | 2025-05-12 | 2025-05-14 | $24.99 | $166K | -4.0% | -6.7% | -14.7% |
| PRVA | SELL | 2025-04-30 | 2025-05-02 | $23.33 | $161K | +4.5% | -1.8% | -16.1% |
| PRVA | SELL | 2025-04-02 | 2025-04-03 | $22.38 | $252K | +11.3% | +5.7% | +0.8% |
| PRVA | SELL | 2025-03-10 | 2025-03-12 | $24.21 | $283K | -0.0% | +0.7% | -3.9% |
| PRVA | SELL · 10b5-1 | 2025-02-14 | 2025-02-19 | $25.15 | $2.5M | -1.0% | -7.4% | -2.7% |
| PRVA | SELL | 2024-05-10 | 2024-05-13 | $17.88 | $40K | -12.2% | -4.6% | +5.2% |
| PRVA | SELL | 2024-04-30 | 2024-05-02 | $18.42 | $43K | -4.1% | -7.9% | +10.2% |
| PRVA | SELL | 2024-04-02 | 2024-04-04 | $17.77 | $140K | -2.5% | +5.1% | -6.6% |
| PRVA | SELL | 2023-05-01 | 2023-05-03 | $27.42 | $95K | +7.5% | +1.4% | +13.1% |
| PRVA | SELL | 2023-04-03 | 2023-04-05 | $27.62 | $304K | -6.6% | +5.0% | -7.1% |
| PRVA | SELL | 2022-10-05 | 2022-12-20 | $35.65 | $279K | -4.5% | +8.1% | +15.9% |
| PRVA | SELL | 2022-09-06 | 2022-09-08 | $40.14 | $494K | -12.1% | -19.0% | -46.6% |
| PRVA | SELL | 2022-08-05 | 2022-08-08 | $37.66 | $2.3M | -6.0% | +8.1% | -24.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.